Indications of PD-1 Inhibitors for Advanced cSCC
Wednesday, April 14, 2021 at 4:00pm Pacific/5:00pm Central/ 7:00pm Eastern
Webinar will be 1 hour long.
The webinar will review the current data supporting the approvals for immune checkpoint inhibitors. Cases will be utilized to highlight the direct clinical application.
At the conclusion of the activity, participants will be able to:
Define the current approved indications for immune checkpoint inhibitors.
Kevin Emerick, MD, Massachusetts Eye & Ear Infirmary
Gina Jefferson, MD, MS, The University of Mississippi Medical Center
Miriam Lango, MD, MD Anderson Cancer Center
David Miller, MD, PhD, Massachusetts General Cancer Center
Matthew Witek, MD, MS, University of Maryland School of Medicine
Past Instructional Courses
(click the banner to access the recording)